December 2024

Graduation in Science B.Pharm, Life Sciences, B.Sc., Biotech, Zoology, Botany, etc. with PG Diploma in Clinical Research is mandatory.

Candidates experience in Sterile Quality Assurance, covering QMS, Validation, IPQA, and related areas.

RM, FG, Stability, Analytical Instrumentation-HPLC, UV and Dissolution. Handling of LIMS, Empower software, HPLC Waters SAP

Environment Monitoring, QMS, Routine and Non-Routine Analysis, PET, Sterility, BET and Water Testing. QMS, IPQA, AQA, Qualification, Process and Cleaning Validation, Aseptic Core Monitoring

BioMatrix Healthcare Private Limited, 100% export-oriented company headquartered at Ahmedabad, Gujarat, India, was established in 2007 with a thought of Supporting Life Worldwide.

Updated results from the OlympiA Phase III trial showed AstraZeneca and MSDs Lynparza olaparib demonstrated sustained, clinically meaningful improvements in overall survival , invasive disease-free survival IDFS and distant disease-free survival DDFS at six years for patients with germline BRCA-mutated gBRCAm HER2-negative high-risk early breast cancer.

Pfizer Inc. and Alliance Foundation Trials, LLC announced results from the Phase 3 PATINA trial demonstrating that the addition of IBRANCE palbociclib to current standard-of-care first-line maintenance therapy following induction chemotherapy resulted in statistically significant and clinically meaningful improvement in progression-free survival by investigator assessment in patients with hormone receptor-positive

The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic—an effective antiviral that has since successfully treated millions. But like many antivirals before it, scientists know that at some point, Paxlovid is likely to lose some efficacy due to drug resistance. Researchers working to stay ahead of such emerging threats have now identified a wholly new way to treat SARS-CoV-2 infections—work that may have even broader implications.